An exchange: The market sees a phased rebound but divergence continues, with capital inflows and structural recovery occurring simultaneously.
According to the latest weekly report from a certain exchange, the easing of macro risks has led the market to rebound. Last week, the S&P 500 rose by 3.48%, the Nasdaq increased by 4.12%, and WTI crude oil dropped by over 14% within the week. The crypto market also recovered in tandem, with BTC rising 2.5% and ETH gaining 3.9%, accompanied by net capital inflows into spot ETFs—approximately $786 million for BTC and about $187 million for ETH. However, market sentiment remains in the “extreme fear” range, with capital inflows proceeding relatively cautiously.
In terms of asset and industry developments, structural opportunities continue to emerge. Thanks to fundamental improvements brought by network performance upgrades, TON surged 15.9%. Meanwhile, the Hong Kong Monetary Authority issued its first batch of stablecoin licenses to Anchorpoint and HSBC, marking the official implementation of the compliant digital currency framework.
On the financing front, activity remained relatively robust, with 11 deals completed last week and total disclosed funding reaching approximately $73.7 million—a significant rebound compared to the previous week. Funds mainly flowed into infrastructure and early-stage innovation sectors. Overall, while the market has experienced a short-term recovery, structural differentiation continues, and capital and narratives are gradually focusing on areas with fundamental strength and regulatory compliance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go
Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.
RBA Minutes: Case for rates to act promptly to keep inflation expectations anchored
